World
Concern over 'rushed' approval for India Covid jab
BBC
January 5, 2021 7:12 am
Experts have raised concerns over India’s emergency approval of a locally-produced coronavirus vaccine before the completion of trials.
On Sunday, Delhi approved the vaccine – known as Covaxin – as well as the global AstraZeneca Oxford jab, which is also being manufactured in India.
Prime Minister Narendra Modi touted the approval as a “game changer”.
Article continues after advertisement
The head of Bharat Biotech, which makes Covaxin, defended the approval process, but health experts warn it was rushed.
Health watchdog All India Drug Action Ntework said it was ‘shocked’.
Sponsored Links
Claim Your Money Today!
Please click here to check and inform us at [email protected] to help us settle. Check List
By LICI
Extra Weekly Specials
Don't miss out on the amazing specials on offer this week at all Extra branches. Click Here to View
By Extra Supermarket
Spend and Win Postshop Shopping Vouchers
Spend $30 or more at our Postshop or eShop and be in the draw. Shop Online Here
By Post Fiji
